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ABSTRACT 
 
 Less than 10% of pregnant women consume the AI of choline, a nutrient 
important for development. In animals, maternal choline supplementation (MCS) 
improves offspring behavior, but few studies have tested this in humans. In the present 
RCT, MCS caused higher placental and lower cord NR3C1 methylation, which is 
opposite the pattern associated with early adversity and offspring behavior problems in 
prior studies. We tested the independent associations between MCS and NR3C1 
methylation and child behavior (BASC-III; n=21) at age 7, using adjusted linear 
regression.  Mothers consumed 480 or 930 mg choline/d during the 3rd trimester. Cord 
blood and placentas were collected at delivery for methylation analysis, which focused 
on average and site-specific NR3C1 methylation. The 930 mg group reported fewer 
emotional self-control problems. Cord CpG 30-32 methylation was associated with 
fewer internalizing and anxiety problems. Results suggest that choline-induced 
changes in NR3C1 methylation may have functional consequences for child behavior. 
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in HPA axis reactivity and stress related diseases in the US population. 
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1 
Introduction 
 Dietary choline requirements increase during pregnancy to support fetal and 
placental growth, but there is growing concern that many pregnant women do not 
consume enough choline to keep up with these demands. Choline is the precursor to 
cell membrane components sphingomyelin and phosphatidylcholine and to the 
neurotransmitter acetylcholine. These three compounds are required in abundance 
during early development to support the rapid growth, differentiation, and myelination 
of neurons (Lauder and Schambra, 1999). Choline also supplies methyl groups for 
epigenetic modifications (i.e., DNA and histone methylation) in the fetus and placenta, 
two tissues that exhibit remarkable epigenomic plasticity. Animal studies have shown 
that methyl donor supplementation during pregnancy can induce stable epigenetic 
changes in the offspring  (Davison et al., 2009; Lillycrop et al., 2005; Mehedint et al., 
2010) and lead to sustainable functional alterations across the lifespan (Kovacheva et 
al., 2009; Waterland et al., 2008).  The choline utilized for these critical 
developmental functions is supplied almost entirely by the maternal diet (Yan et al., 
2012).  Pregnancy depletes maternal choline pools in individuals consuming the 
recommended amount (Adequate Intake or AI) (Yan et al., 2012; Zeisel et al., 1995), 
and even consuming double the AI does not prevent a reduction in choline stores and 
choline metabolites relative to non-pregnant women (Yan et al., 2012). Less than 9% 
of pregnant women even consume the AI (Wallace and Fulgoni, 2017), and it is not 
known whether such low intake puts the children at increased risk of cognitive or 
psychosocial impairment throughout the lifespan.   
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 Animal studies have repeatedly demonstrated that increasing maternal choline 
intake (above levels provided by standard chow) improves several domains of 
offspring cognition. Providing dams with a choline-deficient diet during pregnancy 
has been shown to impair memory and attention in the adult offspring (Meck and 
Williams, 1999, 2003).  Conversely, providing pregnant dams with additional choline 
(maternal choline supplementation; MCS) has been shown to exert lasting beneficial 
effects on offspring memory (Meck, 1988; Meck and Williams, 1999) and attention 
(Meck et al., 2007; Mohler et al., 2001; Moon et al., 2010).  Few studies have 
examined this important question in humans. Observational studies have shown that 
higher maternal choline intake (Boeke et al., 2013) and higher maternal plasma free 
choline (Wu et al., 2012) are associated with improved offspring cognition. A recent 
randomized controlled trial (RCT) demonstrated that MCS (930 vs 480 mg choline/d) 
significantly improved infant visual processing speed, and markedly improved infant 
explicit memory (Caudill et al., in press), two early predictors of child IQ (Dougherty 
and Haith, 1997). To the best of our knowledge, only one other study has examined 
the effects of MCS (750 mg PtdCh/d, equivalent to 100 mg choline/d, versus placebo) 
on infant cognition (Cheatham et al., 2012). This study found no main effect for 
choline, but evidence of moderation by genotype led the authors to conclude that 
genetic differences may have masked the effects of the intervention. The results of 
these studies, although mixed, provide suggestive evidence that the effects of 
increased maternal choline in animals may translate to humans. 
 The observed benefits of MCS also extend to offspring behavioral and 
psychosocial functioning, based on the rodent literature. MCS increases object-
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exploration and diminishes age-related decline in open-field exploration (both 
indicative of lower fearfulness) in the offspring (Glenn et al., 2008). Maternal choline 
supplementation improves offspring emotion regulation (Cheng et al., 2008) , and 
ameliorates deficits in behavioral and emotional regulation in rodent models of autism 
(Langley et al., 2015), Rett syndrome (Nag and Berger-Sweeney, 2007; Nag et al., 
2008; Ward et al., 2009), and Down syndrome (Moon et al., 2010). In a murine model 
of Down syndrome, MCS partially attenuated the disruptive effect of committing an 
error on performance in a vigilance task (Moon et al., 2010).   Finally, other studies 
have shown that MCS mitigates the effects of adverse in utero exposures including 
alcohol (Thomas et al., 2000, 2004, 2007, 2009), iron deficiency (Kennedy et al., 
2014; Tran et al., 2016), and maternal stress (Schulz et al., 2014a) on offspring 
behavioral development.  
 Few studies have evaluated the effects of varying maternal choline intake on 
offspring behavior and psychosocial functioning in humans. One trial reported 
significantly improved sensory gating (indicative of reduced risk of later psychiatric 
illness) in infants whose mothers were randomized to receive 5,300 mg PtdCh/d 
during pregnancy relative to placebo controls (Ross et al., 2013). A 40-month follow-
up study of these children revealed fewer attention problems and less social 
withdrawal in the supplemented group relative to the controls, as measured by the 
Child Behavior Checklist (CBCL), a parent-report of child behavior. The 
supplemented group also had lower scores (indicating fewer problems) on the five 
other behavior subscales and the externalizing and internalizing composite scales, but 
none of these differences were statistically significant (Ross et al., 2016).  A second 
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RCT also revealed substantially lower parent-reported infant fearfulness at 13 months 
of age among infants whose mothers consumed the higher dose of choline (930 vs 480 
mg choline/d) (Caudill et al, in press). Although limited, the results of these human 
studies align well with the rodent literature in terms of behavioral domains affected by 
maternal choline intake (i.e., internalizing, fearfulness, emotional regulation).   
 Increased maternal choline intake may also improve offspring hypothalamic-
pituitary-adrenal (HPA) axis functioning. In our prior RCT, higher maternal choline 
intake resulted in lower cord blood cortisol at delivery and altered methylation of  the 
HPA-axis regulating genes, CRH and NR3C1, in cord blood and placenta (Jiang et al., 
2012). The HPA axis is the primary neuroendocrine system responsible for generating 
the stress response and maintaining circulating stress hormone (e.g., cortisol) levels 
(Smith and Vale, 2006). Dysregulation of the HPA-axis has been associated with 
internalizing behaviors in the offspring (Goodyer et al., 2001; Lopez et al., 2004). 
Among adults, dysregulation of the HPA-axis is associated with both anxiety and 
depression, in addition to other psychiatric illnesses including schizophrenia, bipolar 
disorder , and PTSD (Benjet et al., 2010; Green et al., 2010; Slopen et al., 2014). The 
role of in utero exposures in the development of mental disorders has been 
increasingly recognized. Prenatal programming of the HPA axis by epigenetic 
modification (i.e., DNA methylation) is one mechanism by which in utero exposures 
modulate risk of these disorders (Heim and Binder, 2012; Palma-Gudiel et al., 2015a; 
Parade et al., 2016). Large cohort studies have shown that even small exposure-
associated methylation differences (i.e. 2-10%) can be statistically significant and 
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clinically meaningful, due to low natural variation in DNA methylation across 
individuals(Breton et al., 2017).  
 The glucocorticoid receptor gene, NR3C1 (Benjet et al., 2010), is perhaps the 
most widely-studied gene in the context of epigenetic programming of human 
behavior. In a landmark study by Weaver et al., maternal neglect resulted in higher 
NR3C1 methylation in offspring hippocampal DNA (Weaver et al., 2004). Altered 
NR3C1 methylation has been observed in infants exposed to early life adversity 
including maternal neglect (Francis et al., 1999; Liu et al., 1997; Weaver et al., 2004) 
and maternal smoking (Stroud et al., 2016a), psychosocial stress (Mulligan et al., 
2012; Palma-Gudiel et al., 2015a), and depression during pregnancy (Oberlander et 
al., 2008; Palma-Gudiel et al., 2015b; Stroud et al., 2016b). Variation in NR3C1 
methylation in fetal tissues (i.e., cord leukocytes and placenta) also predicts infant 
neurobehavior (Bromer et al., 2013; Conradt et al., 2013) and infant cortisol stress 
response (Oberlander et al., 2008). Finally, NR3C1 methylation may mediate the 
effects of in utero exposures on offspring behavior.  Two recent studies reported 
independent additive effects of maternal depression (Conradt et al., 2013) and 
maternal smoking (Stroud et al., 2016a) with NR3C1 methylation on infant 
neurobehavior.  A third study  revealed  that NR3C1 methylation in child saliva 
significantly mediated the effects of prenatal stress on childhood internalizing 
behaviors (Parade et al., 2016).  
 One prior RCT reported marked effects of maternal choline intake on 
methylation of the cortisol-regulating genes NR3C1 and CRH (corticotropin releasing 
hormone) in cord blood and placenta. Furthermore, infants of supplemented moms 
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exhibited a reduced cortisol response to the stress of labor and delivery, suggesting a 
functional effect of these choline-induced epigenetic modifications (Jiang et al., 2012). 
Given prior associations between fetal NR3C1 methylation and childhood behavior, 
and given the effects of MCS on fetal NR3C1 methylation, we hypothesized that 
NR3C1 methylation may mediate the hypothesized effects of MCS on child behavioral 
and psychosocial outcomes. If this is the case, then examining the association between 
NR3C1 methylation and child behavior may provide a much stronger analysis than 
testing the effects of MCS on child behavior directly. 
  The present study is a 7-year follow-up of the i mother-child pairs from a prior 
randomized controlled maternal choline feeding study during the third trimester of 
pregnancy. At 7 years of age, a more complete behavioral assessment is possible, 
compared to the assessment conducted during infancy. The present study has three 
aims: First, we aim to characterize the effects of MCS on child behavior (primary 
analysis). We hypothesize that higher maternal choline intake will be associated with 
fewer problems in domains shown to be sensitive to MCS in previous animal and 
human studies (i.e., internalizing, anxiety, withdrawal, and emotional self-control). 
Second, we aim to replicate the findings of Jiang et al. with regard to MCS and 
NR3C1 methylation in our smaller follow-up sample (confirmatory analysis). Third, 
we will evaluate whether cord and placental NR3C1 methylation differences within 
our sample predict child behavior outcomes (plausibility analysis). Given that MCS 
strongly influenced NR3C1 methylation in this sample (Jiang et al., 2012), evidence 
for a relationship between methylation and behavior would support our hypothesis that 
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MCS influences child behavior via downstream changes in cord and placental NR3C1 
methylation (Figure 1). 
 
 
 
 
 
 
 
 
 
FIGURE 1 
Overall analysis plan. In the primary analysis, we examined the relationship between MCS 
and child behavior. In a second, confirmatory analysis, we aimed to replicate the findings of 
Jiang et al. regarding the effects of MCS on offspring NR3C1 methylation in our reduced 
sample size (n=18/19 for cord/placenta vs n=23/24 in Jiang et al.). In our third, plausibility 
analysis, we examined the association between NR3C1 methylation and child behavior. 
Methylation served as a proxy for MCS in this analysis, given our hypothesized mechanism 
whereby MCS is involved in fetal programming of child behavior via altered NR3C1 
methylation. 
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Methods 
Study Participants 
 This study was a follow-up to a randomized controlled maternal choline 
feeding study conducted at Cornell University. The detailed methods of the original 
trial, which was designed to assess biomarkers of choline metabolism in pregnant 
versus nonpregnant women (ClinicalTrials.gov as NCT101127022) have been 
described elsewhere (Yan et al., 2012). Briefly, between January 2009 and October 
2008, third-trimester pregnant (gestational week 27) women were randomized (n=29) 
to either 480 (approximately the AI for choline; n=12) or 930 (n=12) mg choline/d for 
12-weeks. Choline was supplied from dietary sources (380 mg/d; all participants) and 
choline chloride supplements (100 or 550 mg/d for the 480 and 930 mg choline/d 
groups, respectively). All food and beverages were provided by study investigators, as 
detailed in Yan et al.( Yan et al., 2012). Participants consumed 1 meal/d on-site and 
received the remaining meals, snacks, and beverages as take-aways. Participants also 
received daily prenatal multivitamins (Pregnancy Plus; Fairhaven Health, Bellingham, 
WA, USA) and DHA supplements (200 mg; Neuromins; Nature’s Way Products, 
Lehi, UT, USA) as well as a potassium and magnesium supplement (General Nutrition 
Corp, Pittsburgh, PA, USA) 3X/wk. The daily choline supplement was consumed 
during the onsite meal under the supervision of study investigators. Participants 
continued on their choline supplements after completing the 12-week feeding study 
until the delivery of their babies. This resulted in slight variation in the total number of 
days on the supplement based on differences in gestational age at study entry and 
delivery.  
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 Twenty-six of the 29 women who started the feeding study completed it.  
Women who completed the choline feeding study were re-contacted for participation 
in the follow-up study between July 2016 to May 2017. A total of 21 mother-child 
pairs consented to participate (Figure 2).  
 
  
 Parents brought their children to Cornell University for two cognitive testing 
sessions on consecutive days within 7 months after the child’s 7th birthday. These 
sessions were part of a larger study to evaluate the effects of maternal choline intake 
on child behavior, cognition, and hypothalamic-pituitary-adrenal (HPA) axis 
reactivity.  Children completed a variety of cognitive tasks while the accompanying 
Randomly assigned during pregnancy 
(n=29 women) 
480 mg choline/d (n=16) 930mg choline/d (n=13) 
12 children with behavior data 
at age 7 y 
9 children with behavior data 
at age 7 y 
13 completed intervention 13 completed intervention 
Follow-up at 7 y 
8 children with behavior and 
cord/placenta NR3C1 
methylation data at age 7 y 
10 children with behavior and 
cord/placenta NR3C1 
methylation data at age 7 y 
1 missing placenta 
1 missing cord blood 
1 lost to follow-up 
1 missing placenta 
4 lost to follow-up 
FIGURE 2  
Sample flowchart for the assessment of the impact of maternal choline 
supplementation and NR3C1 promoter methylation on child behavior at 7 y of age 
Parent Study 
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parent completed behavior and health history surveys.  For the purpose of this study, 
we investigated the behavior survey data to assess the association of choline dose with 
child internalizing behaviors, anxiety, withdrawal, and emotional self-control.  
 
Sample Collection 
 Cord venous blood and placentas were obtained from 18 and 19 of the women 
in this study, respectively (n=9-10 per choline intake group). Cord venous blood was 
collected in 10 mL EDTA tubes (Vacutainer; Becton-Dickinson, Franklin Lakes, NJ, 
USA) immediately after delivery (Yan et al., 2012). Placenta samples were processed 
within 60-90 minutes of delivery, and a majority were processed within 10-30 
minutes. Placentas were processed as follows: The amniotic sac was removed and the 
placenta was visually divided into 4 quadrants. Full thickness biopsies (0.5 cm x 0.5 
cm x placenta depth) were obtained from the center of each quadrant, rinsed with PBS, 
and flash frozen in liquid nitrogen. Biopsies from each of the 4 quadrants were pooled 
and ground in liquid nitrogen for DNA extraction(Jiang et al., 2012). The placenta is a 
heterogeneous tissue, so DNA methylation measurements in this study represent 
average methylation patterns across a subset of placental cells.  
 
Measurements 
NR3C1 Methylation 
 Genomic DNA was extracted via the DNeasy blood and tissue kit (Qiagen), 
and methylation was measured by base-specific cleavage and mass spectrometry  
(Hartmer et al., 2003). Briefly, 1µg extracted DNA was bisulfite treated using the EZ 
  
 
11 
96-DNA methylation kit (Zymo, Irvine, CA, USA) and the sequence of interest, the 5’ 
untranslated exon 1F of NR3C1, was PCR-amplified using the bisulfite-treated DNA 
as the template and primers that incorporate the T7 tag. Sequences for both the primers 
and the NR3C1 target region have previously been published by Jiang et al., (Jiang et 
al., 2012).  Amplification products were analyzed using the MassArray EpiTyper 
system (Sequenom, San Diego, CA, USA) at the Cornell Life Sciences Core 
Laboratories Center (Cornell University). Results are reported as percent cytosine 
methylation across the entire region (average NR3C1 methylation) and at the level of 
specific cytosine-phosphate-guanine (CpG) dinucleotides. The EpiTyper system 
cannot distinguish adjacent CpG sites, so in some cases site-specific results are 
reported as an average across 2-3 adjacent CpG dinucleotides (Jiang et al., 2012). 
 The NR3C1 exon 1F region contains 47 CpG sites. We analyzed average 
methylation across the 47 sites and methylation at specific a priori selected CpG units 
in relationship to child behavior outcomes.  These units, which include CpGs 30-32, 
and CpGs 37-38, correspond to canonical NGFI-A (a transcription factor) binding 
regions. Methylation of these units is influenced by maternal care (Weaver et al., 
2004) and early life stress (Hompes et al., 2013; van der Knaap et al., 2014; 
Oberlander et al., 2008; Radtke et al., 2011; Romens et al., 2015; Stroud et al., 2016; 
Tyrka et al., 2015), and has been shown to modulate NR3C1 expression (McGowan et 
al., 2009) and stress reactivity across the lifespan (Edelman et al., 2012; Stroud et al., 
2014, 2016b).   
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Child Behavior  
 Child behavior was assessed using the Behavior Assessment System for 
Children, Third Edition, Parent Rating Scale, Child Form (BASC-III; Reynolds and 
Kamphaus, 2015) administered to caregivers using an online survey platform 
(Qualtrics Survey Platform, Provo, UT, USA) in the presence of a study investigator 
who was trained to answer questions relating to the instrument. The BASC-III is a 
reliable and valid measure with strong test-retest reliability(Cecil R. Reynolds, PhD 
and Randy W. Kamphaus, PhD, 2015).  In most instances (90.5%), assessments were 
completed by the child’s mother; the father completed the remaining assessments 
(9.5%). 
 The BASC-III provides a comprehensive measure of adaptive and problematic 
child behaviors in home and community settings, and is suitable for children ages 6-11 
years old. Primary outcomes of interest were the Internalizing Behaviors composite 
scale (comprised of three clinical subscales: Depression, Somatization, and Anxiety), 
the Anxiety clinical scale, the Emotional Self-Control scale, and the Withdrawal 
content scale. Parents assessed their children on 175 behaviors using a 4-point scale 
ranging from “Never” to “Almost Always”. Standardized age and sex-specific t-scores 
were calculated relative to the BASC-III normative sample, which included children 
from different ethnicities and designed to “resemble the U.S. population with respect 
to sex, socio-economic status, race/ethnicity, geographic region, and special-education 
classification”. Possible t-scores range from 0-100, with a mean of 50 and standard 
deviation of 10 in the normative sample. Scores between 60-69 are considered “At-
Risk”, and scores greater than 70 are considered “clinically significant” (Cecil R. 
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Reynolds, PhD and Randy W. Kamphaus, PhD, 2015). Emotional Self Control Scores 
were not available for the normative sample, so raw scores were used for all analyses 
involving this scale. For all of the scales analyzed, higher scores indicate more 
problems. 
  
Covariates 
 Maternal and newborn information were obtained from a questionnaire 
administered in the screening phase of the initial feeding study and from medical 
charts at the time of delivery. Maternal information included age, gestational age at 
study entry, education, parity, height, weight, and complications during pregnancy or 
delivery. Newborn information included birth weight, head circumference, gestational 
age, method of delivery, and sex (Yan et al., 2012). Child and caregiver information at 
the 7-year follow-up was obtained from a questionnaire administered using an online 
survey platform (Qualtrics Survey Platform, Provo, UT, USA).  Child information 
included height, weight, race primary language, duration of breastfeeding, family 
history of depression or anxiety, and ”Recent Stressor Index”. The ”Recent Stressor 
Index” score was calculated by summing the number of potentially stressful events 
(from a pre-selected 12-item checklist, Appendix A) experienced by the child in the 
past 12 months.   
 
Ethics 
 The protocols for the feeding trial and for the follow-up behavioral and 
cognitive study were both approved by the Institutional Review Board for Human 
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Participant Use at Cornell University (Ithaca, NY, USA). The feeding trial was also 
approved by the Institutional Review Board at Cayuga Medical Center (Ithaca, NY, 
USA). Written informed consent was obtained from all participants before the feeding 
study, and again before participation in the present study. Child assent was also 
obtained before participation in the present study.   
 
Statistical Analysis 
 The sample size for the feeding study was based on a power calculation that 
predicted differences of 20% in biomarkers of choline metabolism (choline and 
betaine) with a power of 80% at an alpha of 0.05 between choline intake groups. The 
sample size for the follow-up study had 80% power at an alpha of 0.05 to detect a 13-
point difference in behavior t-scores between the two intake groups, assuming a 
standard deviation of 10 (G*Power 3.1, Universitaat Dusseldorf, Dusseldorf, 
Germany). This was an intent-to-treat analysis, so all participants with available data 
were included in the analyses. Statistical analyses were conducted using general linear 
models (glms) in SAS 9.4 (SAS Institute Inc., Cary, NC, USA) and all tests were two-
tailed.  
 
Primary Analysis: Maternal Choline Intake and Child Behavior 
 We examined the effects of maternal choline supplementation on four indices 
of child behavior outcomes (Internalizing Problems, Anxiety, Withdrawal, and 
Emotional Self Control) using unadjusted models. Sex was included as a covariate in 
the unadjusted model for Emotional Self-Control, because raw scores are not 
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comparable across sexes (Cecil R. Reynolds, PhD and Randy W. Kamphaus, PhD, 
2015). For adjusted analyses (Models 2 and 3), we pre-specified inclusion of 
covariates known to be prognostic of child internalizing behaviors. In Model 2, we 
included maternal education at randomization, child sex, and pregnancy and delivery 
complications. In Model 3 we added a “Recent Stressor Index” variable (See 
Appendix A) to remove variation in the behavior outcomes that was not likely to be 
due to the exposure. 
 
Confirmatory Analysis: Maternal Choline Intake and Infant DNA Methylation  
 We also aimed to recapitulate the findings of Jiang et. al., which showed that 
maternal choline intake alters offspring DNA methylation (Jiang et al., 2012), in the 
subset of subjects who participated in our follow-up study (n=19 for cord, n=18 for 
placenta). For this supplemental analysis, we conducted unadjusted individual 
contrasts assessing the effect of choline on each NR3C1 methylation site (i.e., average, 
CpG30-32, and CpG37-38) in cord leukocytes and placenta.  
 
Plausibility Analysis: Infant DNA Methylation and Childhood Behavior Patterns 
 We hypothesized that maternal choline supplementation would influence child 
behavior by altering cord and placental NR3C1 methylation, which has been shown to 
predict child behavior (Appleton et al., 2015; Bromer et al., 2013; Conradt et al., 2013; 
Parade et al., 2016; Stroud et al., 2016a) and stress-reactivity (Oberlander et al., 2008; 
Stroud et al., 2016b). We had measurements of NR3C1 methylation in cord blood and 
placenta. In this analysis, NR3C1 methylation is an indicator of response to treatment 
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(Jiang et al., 2012). To explore this, we evaluated the effects of offspring cord and 
placental average NR3C1 exon 1F methylation and methylation at sites CpG 30-32 
and CpG37-38 on child behavior using adjusted models (Model 3 above). We applied 
a Bonferroni correction to adjust for multiple testing (three methylation sites in two 
tissues), and the statistical significance threshold was conservatively set at P=0.008.  
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Results 
 Behavior data was collected for 21 of 26 eligible children (Figure 2). Table 1 
shows demographic characteristics of mothers and children that comprised the 
statistical models for the 480 and 930 mg choline/d groups. Maternal education at 
randomization was significantly higher in the 480 mg choline/d group. This imbalance 
justified the inclusion of maternal education as a covariate in our a priori adjusted 
models (Models 2 and 3).   Five mother-child pairs were lost to follow-up. These 
mothers were not systematically different than the 21 follow-up participants in any of 
the measured covariates. Among those lost to follow-up, 2 women were Caucasian, 3 
were employed full- or part-time, and 2 held graduate degrees. 
 
Maternal Choline Supplementation 
 In the regression model adjusted only for sex (Model 1),  there were  lower 
Emotional Self-Control scores (indicating fewer problems) in the 930 mg choline/day 
group compared to the 480 mg choline/d group (b = -2.28, p=0.10, Figure 3).  Lower 
scores were also reported on the Internalizing Problems, Anxiety, and Withdrawal 
scales in the 930 mg choline/d group compared to the 480 mg choline/d group, 
however none of these results were statistically significant. 
 In the a priori adjusted model (Model 2) of the association between MCS and 
Emotional Self-Control was attenuated.  There was little to no association of MCS 
with Internalizing Problems, Anxiety, or Withdrawal scores in the adjusted analyses, 
and none of the covariates were significantly associated with the behavior outcomes. 
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TABLE 1  Selected characteristics of 21 children who were followed up at age 7 y by treatment
1
 
 
1
P values were determined with the use of the t test for comparisons of means and chi-square test for comparisons of proportions.  
2
Mean ± SD (all such values) 
3
Maternal education was measured as a categorical variable (indicator variables were: 0= H.S. Diploma, 1=Associates or Vocational 
Degree, 2= Bachelor's Degree,  3=Master’s Degree, 4=Doctorate or Professional degree) and analyzed as a continuous variable  
4
See Appendix A for a description of how this was calculated 
5
Behavior Assessment System for Children (BASC-III) Internalizing Problems is a composite score which includes the Somatization, 
Depression, and Anxiety Subscales.  
6
BASC-III Anxiety measures “the tendency to be nervous, fearful, or worried about real or imagined problems” 
7
BASC-III Withdrawal measures “the tendency to evade others or to avoid social contact” 
8
BASC-III Emotional Self Control measures “the ability to regulate one’s affect and emotions in response to environmental changes 
 480 mg  (n = 9) 
930 mg 
 (n = 12) P 
Maternal characteristics at random assignment    
Age (y) 28.4 ± 3.02 27.3 ± 3.8 0.45 
Gestational age (wks) 26.6 ± 1.9 26.9 ± 1.2 0.59 
Education
3 2.8 ± 0.4  1.5 ±  1.1 0.004 
Parity (primiparous/multiparous) 5/4 4/8 0.31 
Pre-pregnancy weight (kg) 61.5 ± 5.6 65.5 ± 11.0 0.33 
Pre-Pregnancy height (cm) 165.7 ± 5.2 164.8 ± 8.3 0.78 
Pre-pregnancy BMI (kg/m
2
) 22.4 ± 1.2 24.0 ± 3.0 0.13 
Offspring characteristics       
Sex (F/M) 3/6 4/8 1 
Birth weight (g) 3468.4 ± 549.3 3457.8 ± 314.7 0.96 
Birth length (cm) 50.2 ± 2.2 50.8 ± 2.4 0.57 
Head circumference at birth (cm) 34.4 ± 1.3 34.1 ± 1.1 0.6 
Gestational age (wk) 40.2 ± 1.5 39.9 ± 0.7 0.57 
Delivery (cesarean/vaginal) 3/6 2/10 0.37 
Pregnancy and/or delivery complications (y/n) 5/4 4/12 0.31 
Duration of breastfeeding (mo) 16.6 ± 8.3 16.9 ± 13.1 0.95 
Height at age 7 y (cm) 128.2 ± 5.7 125.1 ± 5.8 0.23 
Weight at age 7 y (cm) 26.3 ± 4.2 25.6 ± 5.4 0.77 
BMI at age 7 y 15.9 ± 1.3 16.3 ± 2.2 0.68 
Race (Caucasian/African American/Asian/ Native American) 8/0/0/1 7/2/2/1 NA 
Primary Language (English/other) 8/1 9/3 0.42 
Family hx depression and/or anxiety (y/n) 2/7 2/10 0.75 
Recent Stress Index Score
4 1.3 ± 1.0 1.7 ± 0.9 0.43 
Child Behavior Scores    
Internalizing Problems (t-score)
5 51.44 ± 6.86 50.33 ±8.61 0.75 
Anxiety (t-score)
6 50.78 ± 5.76 50.17 ± 8.97 0.86 
Withdrawal (t-score)
7 52.89 ± 10.30 50.83 ± 7.53 0.60 
Emotional Self-Control (raw score)
8 9.44 ± 3.47 7.17 ± 2.44 0.09 
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 To refine our assessment of child behavior to focus on trait-level behaviors 
(i.e., not situationally induced), we explored the addition of a “Recent Stressor Index” 
score to our a priori adjusted model.  In this model, Model 3, the magnitude of the 
estimate for MCS on mean Emotional Self-Control scores was greater than in the 
unadjusted model, but was not statistically significant (b = -3.09, p=0.12). No 
associations of MCS with Internalizing Problems, Anxiety, or Withdrawal were 
observed in these refined adjusted analyses and none of the covariates were 
statistically significant (Table 2).  
FIGURE 3 
FIGURE 3  
BASC-III Emotional Self Control raw scores by maternal choline treatment assignment. 
Higher scores indicate more problems regulating one’s affect and emotions in response 
to environmental changes. The maximum possible score is 30, and the mean and 
standard deviation for the full sample were 8.14 and 3.07 respectively. 
  
 
20 
 
 
 Model 1 Model 2 Model 3 
Behavior Outcome β S.E. P β S.E. P β S.E. P 
Internalizing Problems          
Choline (930 mg/day) -1.11 3.49 0.75 1.78 4.50 0.70 0.20 4.87 0.97 
Sex (M) - - - -1.63 4.00 0.69 3.85 4.75 0.43 
Maternal Education
1 - - - 1.58 2.38 0.52 0.69 2.60 0.79 
Pregnancy and/or delivery 
complications - - - 3.92 4.11 0.35 5.08 4.35 0.26 
Recent Stress Index Score
2 - - - - - - 2.10 2.39 0.40 
Anxiety          
Choline (930 mg/day) -0.61 3.43 0.86 1.25 4.43 0.78 0.41 4.89 0.93 
Sex (M) - - - 0.90 3.94 0.82 0.29 4.76 0.95 
Maternal Education - - - 0.62 2.35 0.79 0.14 2.61 0.96 
Pregnancy and/or delivery 
complications - - - 4.83 4.05 0.25 5.45 4.36 0.23 
Recent Stress Index Score - - - - - - 1.13 2.39 0.64 
Withdrawal          
Choline (930 mg/day) -2.06 3.88 0.60 1.72 5.06 0.74 -0.29 5.44 0.96 
Sex (M) - - - -2.08 4.49 0.65 4.90 5.30 0.37 
Maternal Education - - - 2.87 2.68 0.30 1.74 2.90 0.56 
Pregnancy and/or delivery 
complications - - - 0.48 4.62 0.92 1.96 4.85 0.69 
Recent Stress Index Score - - - - - - 2.68 2.66 0.33 
Emotional Self-Control          
Choline (930 mg/day) -2.28 1.32 0.10 -2.26 1.77 0.22 -3.09 1.88 0.12 
Sex (M) -0.21 1.39 0.88 -0.02 1.57 0.99 1.20 1.83 0.52 
Maternal Education - - - 0.13 0.94 0.89 -0.34 1.00 0.74 
Pregnancy and/or delivery 
complications - - - -0.67 1.62 0.68 -0.05 1.67 0.97 
Recent Stress Index Score - - - - - - 1.11 0.92 0.24 
Note: Model 1 includes maternal choline supplementation dose only. Model 2 includes variables causally associated with child behavior 
outcomes. Model 3 includes a “Recent Stress Index Score” to adjust for uncharacteristic child behavior problems. β’s represent values when all 
variables in each model are entered simultaneously. 
1
Maternal education was measured as a categorical variable (indicator variables were: 0= H.S. Diploma, 1=Associates or Vocational 
Degree, 2= Bachelor's Degree,  3=Master’s Degree, 4=Doctorate or Professional degree) and analyzed as a continuous variable  
2
See Appendix A for a description of how this was calculated 
TABLE 2 
Associations of MCS with child behavior outcomes at age 7 y, as measured by the BASC-III Parent Report 
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Placental NR3C1 Methylation 
 Placental methylation data was available for 19 of 21 children with behavior 
data (Figure 1). Unadjusted regression analyses revealed 0.9% higher NR3C1 exon 1F 
average methylation (p<0.001) and 2% higher CpG 30-32 methylation (p=0.02) in the 
930 mg choline/d group compared to the 480 mg choline/d group (Table 3).  These 
results are of a similar magnitude and direction as the results obtained by Jiang et. al. 
in their adjusted analyses of all women who completed the feeding study and from 
whom placentas were collected (n=24)(Jiang et al., 2012). Higher CpG 37-38 
methylation was also observed in the 930 mg choline/day group, but the effect was not 
statistically significant.  
 
 
 
 
 
 
 
 
 
Adjusted analyses (Model 3) indicated that placental NR3C1 methylation (average 
exon 1F, CpG 30-32, and CpG 37-38) was not a significant predictor of any of 
assessed child behavior outcomes (Table 4). 
 
 Choline (930 mg/d) 
Cord Leukocyte NR3C1 β S.E. P 
CpG 30-32 -0.49 0.88 0.59 
CpG 37-38 -0.63 1.40 0.66 
Exon 1F, Average -0.46 0.27 0.11 
Placental NR3C1 β S.E. P 
CpG 30-32 2.00 0.78 0.02 
CpG 37-38 1.00 0.97 0.32 
Exon 1F, Average 0. 94 0.22 <0.001 
TABLE 3 
The associations of MCS with offspring cord leukocyte and 
placental NR3C1 promoter methylation 
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Cord Leukocyte NR3C1 Methylation  
 Cord leukocyte methylation data was available for 18 of 21 children with 
behavior data (Figure 1). Unadjusted regression analyses revealed lower average 
NR3C1, CpG 30-32, and CpG 37-38 methylation in the 930 mg choline/day group 
relative to the 480 mg choline/day group, however none of these effects were 
statistically significant (Table 2).  
 Adjusted analyses (Model 3) revealed higher cord CpG 30-32 methylation 
among children with higher Internalizing Problems and Anxiety scores. Each 1% 
higher CpG 30-32 methylation was associated with a 2.8-point higher Internalizing 
Problems score (p=0.02) and a 3.2-point greater Anxiety score (p=0.01, Figure 4). 
Similarly, there was a trend for higher Internalizing Problems (p=0.11) and Emotional 
 Behavior Outcome 
Internalizing 
Problems Anxiety  Withdrawal 
Emotional Self-
Control 
Methylation 
Variable  
β S.E. P β S.E. P β S.E. P β S.E. P 
Placental NR3C1             
CpG 30-32 0.99 1.16 0.41 1.80 1.08 0.12 0.50 1.03 0.64 0.26 0.40 0.52 
CpG 37-38 0.57 1.06 0.60 -0.42 1.06 0.70 -1.00 0.89 0.28 0.22 0.35 0.54 
Exon 1F, 
Average 3.27 3.81 0.41 2.48 4.06 0.56 2.87 2.85 0.34 -0.90 1.45 0.55 
Cord Leukocyte 
NR3C1   
           
CpG 30-32 2.80 1.07 0.02 3.19 1.09 0.01 -0.66 1.09 0.56 0.50 0.45 0.29 
CpG 37-38 -0.40 0.79 0.62 -0.67 0.83 0.44 -0.28 0.65 0.67 -0.21 0.27 0.47 
Exon 1F, 
Average 7.36 4.11 0.11 7.22 5.17 0.20 0.48 4.08 0.91 2.92 1.65 0.11 
TABLE 4 
Associations between cord and placental NR3C1 promoter methylation in relation to child 
behavior outcomes at age 7 y, as measured by the BASC-III Parent-Report 
Note: All models are adjusted for child sex, maternal education, pregnancy and/or delivery complications, and recent 
stress. β’s represent the effect of a 1% increase in methylation on child behavior scores 
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Self-Control scores (p=0.11) among children with greater average exon 1F 
methylation (Table 4). 
 
 
 
 
 
 
 
 
 
FIGURE 4 
BASC-III Anxiety t-scores as a function of cord leukocyte NR3C1 CpG 30-32 methylation. In 
adjusted regression analyses, each 1% higher methylation was associated a 3.2% greater 
Anxiety score. 
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Discussion 
 Two major findings were observed in the present study. First, parents reported 
fewer emotional self-control problems in the 930 mg choline/day group compared to 
the 480 mg choline/day group. Second, higher cord leukocyte NR3C1 CpG 30-32 
methylation was associated with more anxiety and internalizing behaviors in the full 
sample.   
 
MCS and Child Behavior  
 Higher maternal choline intake (930 vs 480 mg choline/d) was associated with 
a 3-point decrease in emotional self-control problems. The mean Emotional Self-
Control score in the full sample was 8.14± 3.07, so this association corresponds to a 
full standard deviation increase in emotional self-control problems. The association 
persisted across all 3 models, suggesting that the choline effect was not highly 
sensitive to adjustment. The observed benefits of maternal choline supplementation 
(MCS) on child emotional self-control are consistent with the results of prior rodent 
studies. A study by Cheng et al. reported less “burst responding” (an indicator of 
frustration) among MCS rats versus controls during an operant conditioning task, 
suggesting a superior ability to regulate emotional reaction among the MCS rats 
(Cheng et al., 2008).   In a second study, MCS attenuated the heightened “emotional 
disruption” typically observed in a mouse model of Down syndrome after committing 
an error during testing on an attention task (Moon et al., 2010).  The present study is 
the first to demonstrate that the observed benefits of MCS on offspring emotional 
regulation may translate to humans. 
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 We did not observe any meaningful associations of maternal choline intake 
with withdrawal, anxiety, or internalizing problems. We had predicted effects in these 
domains, based on prior rodent studies, which have shown fewer anxiety-related 
behaviors in offspring of MCS dams (Schulz et al., 2014b; Thomas et al., 2004) and 
one prior human study that showed less social withdrawal  among 40-month-old MCS 
offspring relative to unsupplemented controls, based on parent report (Ross et al., 
2016).  
 Additional findings by Ross et al. regarding child CHRNA7 genotype may 
explain why they found effects of MCS on child withdrawal while we did not (Ross et 
al., 2016). Ross et al. reported that MCS attenuated withdrawal, but only in children 
with particular CHRNA7 genotypes at rs3087454, specifically those with the AC and 
CC genotypes (Ross et al., 2016). Frequency of the CHRNA7 rs3087454  minor C 
allele predicts attention problems (Hyde et al., 2016) and lifetime risk of various 
mental disorders including attention deficit hyperactivity disorder (ADHD; Williams 
et al., 2012), autism spectrum disorder (ASD; Allen-Brady et al., 2010), and 
schizophrenia (Freedman et al., 1997). These findings suggest that the potential-to–
benefit from MCS may be greatest in children with at least one CHRNA7 rs3087454 
minor allele.  Failure to adjust for CHRNA7 genotype in the present study may prevent 
us from detecting effects of MCS on child outcomes that depend on an upregulation of 
this pathway.      
 Alternatively, it is also possible that emotion regulation is more strongly 
affected by increased maternal choline intake than the other indices of affect (anxiety, 
internalizing).  Emotional self-control scale may have been the most sensitive to MCS 
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because it combines effects on both cognition and emotion, domains which both seem 
to be affected by MCS, based on the animal studies. Emotional self-control measures 
the responsivity of various cognitive functions (i.e., attention and executive function) 
to a variety of emotions (i.e., sadness, frustration, and fear)(Cecil R. Reynolds, PhD 
and Randy W. Kamphaus, PhD, 2015). In contrast, anxiety and internalizing are more 
specific to the affective domain (Figure 5).  
 
FIGURE 5 
The effects of choline on child behavior via three independent developmental pathways. 
Capitalized/bold letters indicate behaviors for which there is some evidence of moderation by 
maternal choline intake from animal or human studies. The various contributions of each pathway 
in programming child behavior is not fully understood. Ptd = Phosphatidylcholine.  
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Fetal Programming of Child Behavior by NR3C1 Methylation 
   We focused our subsequent analyses on DNA methylation as a potential 
mechanism by which MCS may modulate child behavior. Specifically, we examined 
the relationship between NR3C1 methylation and child behavior. A prior study 
showed that MCS altered NR3C1 methylation in cord leukocytes and the 
placenta(Jiang et al., 2012), so the goal of this analysis was to directly evaluate the 
functional consequences of the methylation changes.  The NR3C1 gene, which 
encodes the glucocorticoid receptor (GR), has been implicated in epigenetic 
programming of the offspring HPA axis (Benjet et al., 2010; Oberlander et al., 2008), 
and methylation of this gene is associated with infant neurobehavior  (Appleton et al., 
2015; Bromer et al., 2013; Stroud et al., 2016a). Prior work with our sample showed 
increased placental NR3C1 methylation and decreased cord leukocyte NR3C1 
methylation resulting from higher maternal choline intake (930 mg choline/day vs 480 
mg choline/day; Jiang et al., 2012). Therefore, methylation is a proxy for response to 
the choline treatment in the present study. The relationship between NR3C1 
methylation and child behavior provides the strongest analysis of the effects of choline 
on behavior because it eliminates the variance introduced by subjects who did not 
respond to the choline treatment with changes in NR3C1 methylation (Figure 6).  
 The extent to which increased choline availability increases methylation of 
specific genes, such as NR3C1, may vary across individuals, based on their ability to 
convert choline to betaine, which is modulated by several genetic polymorphisms. For 
example, genetic polymorphisms of the human BHMT gene have been shown to 
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impair methyl-group metabolism (Li et al., 2008) and influence DNA methylation 
(Lupu et al., 2017). If present in our sample, these polymorphisms may have 
attenuated the effects of MCS on cord and placental DNA methylation. Consequently, 
if some of the effects of MCS on child behavior are mediated by effects on NR3C1 
methylation, we would expect NR3C1 methylation to be a better predictor of child 
behavior than maternal choline intake because it eliminates the variance introduced by 
those who did not respond to the choline treatment with increased methylation.  
 
 
 
 
 
FIGURE 6 
A proposed mechanism by which higher maternal choline intake results in fewer child 
behavior problems via altered methylation of cord and placental NR3C1 methylation. Given 
the associations between MCS and NR3C1 methylation in our sample (Pathways 1 and 2), 
NR3C1 is a proxy for response to the choline treatment. The effect of MCS on NR3C1 
methylation is sensitive to various effect modifiers. Therefore, the associations between 
NR3C1 methylation and child behavior problems (Pathways 3 and 4) provide a stronger 
analysis of the possible effects of MCS on child behavior. Pathway 5 suggests a possible 
mechanism by which placental NR3C1 methylation may influence fetal NR3C1 methylation.  
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 In this plausibility analysis, NR3C1 methylation is viewed as an indicator of 
response to the choline treatment. In our sample, MCS caused higher average 
placental NR3C1 promoter methylation and higher placental NR3C1 CpG 30-32 
methylation.  In contrast, in cord leukocytes, MCS caused lower average NR3C1 
promoter methylation (Jiang et al., 2012). Notably the pattern of effects in both 
placenta and cord leucocytes is opposite to that produced by early stress and other 
environmental adversities.  Specifically, decreased placental NR3C1 methylation is 
associated with maternal smoking (Stroud et al., 2016a),chronic war stress (Kertes et 
al., 2016), and depression (Conradt et al., 2013) during pregnancy. In contrast, 
increased cord leukocyte NR3C1 methylation is associated with maternal chronic war 
stress (Kertes et al., 2016), depression (Oberlander et al., 2008), and anxiety (Hompes 
et al., 2013; see Palma-Gudiel et al., 2015b for review). Taken together, these results 
suggest that maternal choline intake may offer some protection against some of the 
effects of in utero stress adversity on epigenetic programming of the NR3C1 gene. 
 The pattern of changes in NR3C1 methylation produced by MCS are in the 
direction of improved behavioral and cognitive outcomes, based on prior studies 
evaluating methylation of this gene in relation to early life stressors. For example, 
higher placental NR3C1 methylation has been associated with better infant attention, 
self-regulation, habituation, and quality of movement (Appleton et al., 2015; Bromer 
et al., 2013; Stroud et al., 2016a). Second, higher placental (Stroud et al., 2016b) and 
lower cord (Oberlander et al., 2008) NR3C1 methylation have been associated with 
better infant stress-regulation. Moreover, several studies have shown that cord and 
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placental NR3C1 methylation mediate the effects of in utero adversity on offspring 
behavior (Appleton et al., 2015; Conradt et al., 2013) and stress-regulation 
(Oberlander et al., 2008; Stroud et al., 2016a). Based on these results, we anticipated 
that higher placental NR3C1 methylation and lower cord NR3C1 methylation would be 
associated with fewer behavior problems.  
 Some observations in the present study are consistent with this prediction: We 
observed associations between NR3C1 methylation and behavior in the anticipated 
directions, but only cord NR3C1 CPG 30-32 methylation was a significant predictor of 
child behavior. Each 1% increase in CpG 30-32 methylation was associated with a 
2.8-point increase in internalizing problems and a 3.2-point increase in anxiety. We 
were particularly interested in methylation at this site (CpG 30-32) because of its 
demonstrated ability to block NR3C1 expression in rodent (Weaver et al., 2004) and 
human (McGowan et al., 2009) cell lines. NR3C1 encodes the glucocorticoid receptor 
(GR). The control of fetal exposure to glucocorticoids is critical to the normal 
programming of the developing infant’s neural circuitry. The placenta modulates fetal 
exposure to maternal cortisol, and this function is linked, in part, to the activities of 
CRH and NR3C1.  (Myatt, 2006; Paquette et al., 2016). The effects of MCS on 
methylation of these two genes would have the effect of reducing fetal exposure to 
maternal glucocorticoids, and possibly lowering HPA stress reactivity in the child.    
 
 
 
 
  
 
31 
 
Conclusions 
 The study findings suggest that increased maternal choline intake during the 
third trimester of pregnancy may improve offspring emotional self-control at age 7. A 
prior study showed that higher maternal choline intake was associated with higher 
placental and lower cord NR3C1 methylation, which is opposite the pattern of effects 
produced by prenatal adversity. In this study, we showed that these NR3C1 
methylation patterns, modulated by maternal choline intake, may have functional 
consequences for child internalizing behaviors. NR3C1 is the most widely-studied 
gene in the context of epigenetic programming of the HPA-axis. To the best of our 
knowledge, this is the first study to assess matched cord and placental NR3C1 
methylation in relationship to child behavior outcomes. In light of these findings, 
maternal choline supplementation may have the potential to mitigate the effects of in 
utero stress exposure on child behavior. Future studies are needed to replicate these 
results in larger cohorts and deepen our understanding of the pathways whereby 
maternal choline intake modulates child behavior.
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APPENDIX A 
Recent Stressor Index* 
 
This checklist includes events that children may find bad or upsetting. If an event DID 
happen to your child in the LAST 12 MONTHS, tick the box under the word ‘YES’. If 
the event did not happen to your child, tick the box under ‘NO’. 
 
Yes No  
  Someone special to my child moved away (non-family) 
  Someone in our family was really sick or injured 
  My child was teased or bullied 
  My child’s pet died, got sick, lost or injured 
  My child was really sick or injured 
  My partner and I split up 
  My child saw something bad happen (e.g., car accident, someone being robbed) 
  Someone in our family died 
  Someone broke into our house 
  My child was in a fight (not with people in our family) 
  Someone special to my child was really sick or injured (non-family) 
  Someone special to my child (who is not in our family) died 
 
*This checklist has been adapted from the “Child and Adolescent Survey of 
Experiences: Parent Version” developed by the Center of Emotional Health at 
Macquarie University. Items were selected based on: 1) Propensity to elicit 
internalizing behaviors in a child, and 2) outside of the child’s control (i.e., not a result 
of a child’s intrinsic behavior patterns). The recent stressor index score was calculated 
by summing the number of events for which a parent selected ‘YES’. 
 
 
 
